Sustained release intravitreal dexamethasone

Journal of Ocular Pharmacology and Therapeutics

Volumn 12, Issue 1, 1996, Pages 57-63

  Hainsworth, Dean P ^a   Pearson, P Andrew ^a   Conklin, John D ^a   Ashton, Paul ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NEW ENGLAND EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ETHYLENE VINYL ACETATE COPOLYMER; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG FORMULATION; DRUG IMPLANTATION; DRUG RELEASE; ELECTRORETINOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; PHARMACEUTICS; RABBIT; SUSTAINED RELEASE PREPARATION; VITREORETINOPATHY; VITREOUS BODY;

EID: 0030059439     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1996.12.57     Document Type: Article

References (17)

1. Machemer R. and Laqua H. A logical approach to the treatment of massive periretinal proliferation. Trans. Am. Acad. Ophthalmol. Otolaryngol. 85: 584-593, 1978.
2. McCuen B.W., Bessler M., Tano Y., Chandler D., Machemer R. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am. J. Ophthalmol. 91: 785-788, 1981.
3. Tano Y., Sugita G. and Abrams C. Inhibition of intraocular proliferation with intravitreal corticosteroids. Am. J. Ophthalmol. 89:131-136, 1980.
4. Tano Y., Chandler D.B., McCuen B.W. and Machemer R. Glucocorticosteroid inhibition of intraocular proliferation after injury. Am. J. Ophthalmol. 91:184-189, 1981.
5. Sunalp M., Wiedemann P. and Sorgente N. Effects of cytotoxic drugs on proliferative vitreoretinopathy in the rabbit cell injection. Curr. Eye Res. 3: 619-623, 1984.
6. Chandler D.B., Hida T., Sheta S., Proia A.D. and Machemer R. Improved efficacy of corticosteroid therapy in an animal of model of proliferative retinopathy by pretreatment. Graefes Arch. Clin. Exp. Ophthalmol. 225: 259-265, 1987
7. Lam T.T., Deepak P.E., Xiu-An Z. and Tso M.O.M. Transscleral Iontophoresis of Dexamethasone. Arch. Ophthalmol. 107: 1368-1371, 1989.
8. Chandler D.B., Rozakis G., De Juan E. and Machemer R. Effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy. Am. J. Ophthalmol. 99: 686-690, 1985.
9. Smith T.J., Pearson P.A., Blandford D.L., Brown J.D., Goins K.A., Hollins J.A., Schmeisser E.T. Glavinos P. Baldwin L.B. and Ashton P. Intravitreal sustained release ganciclovir. Arch. Ophthalmol. 110: 255-258, 1992.
10. Blandford D.L., Smith T.J., Brown J.D., Pearson P.A., Ashton P. Subconjunctival sustained release 5-fluorouracil. Invest. Ophthalmol. Vis. Sci. 33: 3430-3435, 1992.
11. Anand R., Nightingale S.D., Fish R.H., Smith TJ and Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch. Ophthalmol. 111: 223-227, 1993.
12. Martin D.F., Parks D.J., Mellow S.D. Ferris F.L., Walton R.C. Remaley N.A. Chew E.Y. Ashton P., Davis M.D. and Nussenblatt R.B. Treatment of cytomegalovirus retinitis with an intraocular sustained -release ganciclovir implant. Arch. Ophthalmol. 112: 1531-1539, 1994.
13. Ruhmann A.G. and Berliner D.L. Influence of steroids on fibroblasts. II. The fibroblast as an assay system for topical anti-infiammatory potency of corticosteroids. J. Invest. Dermatol. 49: 123-130, 1967.
14. Blumenkranz M.S., Claffin A. and Hajek A.S. Selection of therapeutic agents for intraocular proliferative disease. Arch. Ophthalmol. 102: 598-694, 1984.
15. Barr C.C. and Blumenkranz M.S. New substances in the treatment of proliferative vitreoretinopathy. Ophthamol. Clin. N. Am. 2: 187-198, 1989.
16. Flower R.J. and Blackwell G.J. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature. 278: 456-459, 1979.
17. Cheng C.K., Berger A.S., Pearson P.A., Ashton P. and Jaffe GJ. Intravitreal sustained release dexamethasone in the treatment of experimental uveitis. Invest. Ophthalmol. Vis. Sci . 36: 442-453, 1995.